Cannabis Production in Canada
Over the five years to 2018, the Cannabis Production industry has transitioned from a single government-sponsored provider of medical cannabis products to a highly competitive industry comprising dozens of private companies. This development has largely been shaped by the Canadian government's ongoing deregulation of medical marijuana consumption, as well as underlying demographic shifts and improving consumer conditions. And while the sale and consumption of non-medical marijuana remains illegal in Canada, growing demand for cannabis products to treat chronic pain and other ailments has resulted in surging revenue growth for most industry operators. The Cannabis Act is expected to be signed into law by summer 2018, which would essentially legalize recreational marijuana for individuals over the age of 18. In turn, this legislation would substantially increase the industry's total customer base. Ultimately, industry revenue is forecast to grow.
The industry includes all companies licensed by Health Canada to cultivate, produce and sell products containing medicinal marijuana. The value of medical marijuana grown in a patient’s home and illegal purchases of cannabis products for recreational use are both excluded from this industry.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook